Racial differences in effectiveness of alpha feto-protein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB: Racial differences in effectiveness of alpha feto-protein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36(2):410-417.
Serum alpha fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HbsAg and anti-HCV status
Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M: Serum alpha fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HbsAg and anti-HCV status. J Hepatol 2001; 34(4):570-575.
Everhart JE (Ed.). Washington D.C.: Government Printing Office. NIH publication number 94-1447
Godley PA, Sandler RS: Liver cancer. In: Everhart JE (Ed.). Digestive diseases in the United States epidemiology and impact. Washington D.C.: Government Printing Office, 1994; pp. 227-241. NIH publication number 94-1447.